Fingerprint
Dive into the research topics of 'High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia
Hagop Kantarjian*, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Srdan Verstovsek, Francis Giles, Mary Beth Rios, Jianqin Shan, Laurie Letvak, Deborah Thomas, Stefan Faderl, Alessandra Ferrajoli, Jorge Cortes
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
359
Scopus
citations